Nicole Guiso

Summary

Affiliation: Institut Pasteur
Country: France

Publications

  1. ncbi request reprint The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010
    Nicole Guiso
    Institut Pasteur, Prevention and Molecular, Paris, France
    Hum Vaccin 7:481-8. 2011
  2. pmc Macrolide-resistant Bordetella pertussis infection in newborn girl, France
    Sophie Guillot
    Institut Pasteur, Paris, France
    Emerg Infect Dis 18:966-8. 2012
  3. pmc Virulence of pertactin-negative Bordetella pertussis isolates from infants, France
    Hélène Bodilis
    Institut Pasteur, Paris, France
    Emerg Infect Dis 19:471-4. 2013
  4. pmc Bordetella petrii infection with long-lasting persistence in human
    Alain Le Coustumier
    Centre Hospitalier, Cahors, France
    Emerg Infect Dis 17:612-8. 2011
  5. doi request reprint Bordetella pertussis: why is it still circulating?
    Nicole Guiso
    Institut Pasteur, Molecular Prevention and Therapy of Human Diseases Unit, Paris, France Centre National de la Recherche Scientifique CNRS, URA3012, France Electronic address
    J Infect 68:S119-24. 2014
  6. doi request reprint Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin
    N Hegerle
    Molecular Prevention and Therapy of Human Diseases, Institut Pasteur, National Centre of Reference of whooping cough and other bordetelloses, Paris, France
    Clin Microbiol Infect 18:E340-6. 2012
  7. pmc The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence
    Eva Trost
    Institut für Genomforschung und Systembiologie, Centrum für Biotechnologie, Universitat Bielefeld, Bielefeld, Germany
    BMC Genomics 11:728. 2010
  8. doi request reprint Bordetella pertussis and pertussis vaccines
    Nicole Guiso
    Institut Pasteur, Molecular Prevention and Therapy of Human Diseases, Paris, France
    Clin Infect Dis 49:1565-9. 2009
  9. pmc Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland
    É Farfour
    Institut Pasteur, Unité Prévention et Thérapies Moléculaires des Maladies Humaines, National Reference Centre of Toxigenic Corynebacteria, a CNRS URA 3012, b Paris, France
    J Clin Microbiol 50:173-5. 2012
  10. ncbi request reprint [Whooping cough from infants to adults]
    Nicole Guiso
    Institut Pasteur Unité Prevention et Thérapie Moléculaires des Maladies Humaines 25, rue du Dr Roux 75724 Paris Cedex 15 URA CNRS 3012
    Bull Acad Natl Med 192:1437-49; discussion 1449-52. 2008

Collaborators

Detail Information

Publications40

  1. ncbi request reprint The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010
    Nicole Guiso
    Institut Pasteur, Prevention and Molecular, Paris, France
    Hum Vaccin 7:481-8. 2011
    ..Adequate diagnostic facilities are lacking in several countries. Improved surveillance and detection will permit a more accurate assessment of the epidemiology of pertussis and the need for vaccination after childhood...
  2. pmc Macrolide-resistant Bordetella pertussis infection in newborn girl, France
    Sophie Guillot
    Institut Pasteur, Paris, France
    Emerg Infect Dis 18:966-8. 2012
    ..DNA sequencing and PCR-restriction fragment length polymorphism showed a 2047 A-to-G mutation in the 3 copies of the 23S rRNA gene. Monitoring for macrolide resistance is essential in infants <6 months of age...
  3. pmc Virulence of pertactin-negative Bordetella pertussis isolates from infants, France
    Hélène Bodilis
    Institut Pasteur, Paris, France
    Emerg Infect Dis 19:471-4. 2013
    ..We analyzed data from France and compared clinical symptoms among infants <6 months old infected by PRN-positive or PRN-negative isolates. No major clinical differences were found between the 2 groups...
  4. pmc Bordetella petrii infection with long-lasting persistence in human
    Alain Le Coustumier
    Centre Hospitalier, Cahors, France
    Emerg Infect Dis 17:612-8. 2011
    ..holmesii, obtained from human respiratory tract infections. Our observations indicate that B. petrii can persist in persons with chronic pulmonary obstructive disease as has been previously demonstrated for B. bronchiseptica...
  5. doi request reprint Bordetella pertussis: why is it still circulating?
    Nicole Guiso
    Institut Pasteur, Molecular Prevention and Therapy of Human Diseases Unit, Paris, France Centre National de la Recherche Scientifique CNRS, URA3012, France Electronic address
    J Infect 68:S119-24. 2014
    ....
  6. doi request reprint Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin
    N Hegerle
    Molecular Prevention and Therapy of Human Diseases, Institut Pasteur, National Centre of Reference of whooping cough and other bordetelloses, Paris, France
    Clin Microbiol Infect 18:E340-6. 2012
    ..pertussis, aP vaccine-induced immunity enabled the number of circulating B. pertussis and B. parapertussis isolates not expressing virulence factors to increase, sustaining our previous hypothesis...
  7. pmc The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence
    Eva Trost
    Institut für Genomforschung und Systembiologie, Centrum für Biotechnologie, Universitat Bielefeld, Bielefeld, Germany
    BMC Genomics 11:728. 2010
    ..To detect potential virulence factors and corresponding gene-regulatory networks in this human isolate, the genome sequence of C. pseudotuberculosis FCR41 was determined by pyrosequencing and functionally annotated...
  8. doi request reprint Bordetella pertussis and pertussis vaccines
    Nicole Guiso
    Institut Pasteur, Molecular Prevention and Therapy of Human Diseases, Paris, France
    Clin Infect Dis 49:1565-9. 2009
    ..Universal adult booster immunization is now possible using pertussis acellular vaccines, which target-and are thus likely to control-the virulence of this bacterium...
  9. pmc Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland
    É Farfour
    Institut Pasteur, Unité Prévention et Thérapies Moléculaires des Maladies Humaines, National Reference Centre of Toxigenic Corynebacteria, a CNRS URA 3012, b Paris, France
    J Clin Microbiol 50:173-5. 2012
    ..Here, we used molecular and phenotypic tools to characterize and compare 42 invasive isolates collected in France (including New Caledonia) and Poland over a 23-year period...
  10. ncbi request reprint [Whooping cough from infants to adults]
    Nicole Guiso
    Institut Pasteur Unité Prevention et Thérapie Moléculaires des Maladies Humaines 25, rue du Dr Roux 75724 Paris Cedex 15 URA CNRS 3012
    Bull Acad Natl Med 192:1437-49; discussion 1449-52. 2008
    ..Surveillance must include the use of standardized diagnostic tests and reagents. Bacterial isolates should be thoroughly characterized at the genomic, transcriptomic and proteomic levels...
  11. ncbi request reprint Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas
    Elisabeth Njamkepo
    Institut Pasteur, Unite de recherche Prevention et Therapie Moleculaires des Maladies Humaines, URA CNRS 3012, 25 rue du Dr Roux 75724 Paris Cedex 15, France
    Microbes Infect 10:1582-6. 2008
    ..We confirmed the influence of pertussis vaccination on circulating isolates and that isolates vary with the pertussis cycle...
  12. pmc Bordetella pertussis, Finland and France
    Valerie Caro
    Institut Pasteur, Unité PTMMH, FRE CNRS 2849, National Center of Reference of Whooping Cough and Other Bordetelloses, Paris, France
    Emerg Infect Dis 12:987-9. 2006
    ..Isolates from both countries were similar genetically but varied temporally...
  13. pmc Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination
    Valérie Bouchez
    Institut Pasteur, Unité Prévention et Thérapie Moléculaires des Maladies Humaines, URA CNRS 3012, Paris, France
    PLoS ONE 3:e2437. 2008
    ..The objective of the study was to analyse the evolution of Bordetella pertussis population and the influence of herd immunity in different areas of the world where newborns and infants are highly vaccinated...
  14. ncbi request reprint Ultrastructural analysis of the interactions between Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica and human tracheal epithelial cells
    Pascale Gueirard
    Unité Prévention et Thérapie Moléculaires des Maladies Humaines, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France
    Microb Pathog 38:41-6. 2005
    ..Even cytotoxic Bordetella species is ultimately killed by human epithelial cells...
  15. pmc Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses
    Valerie Caro
    Institut Pasteur, Centre National de Référence CNR de la Coqueluche et autres Bordetelloses, Paris, France
    J Clin Microbiol 47:3197-203. 2009
    ..However, the risk of false-positive results remains quite high, and we strongly recommend establishment of uniform quality control procedures performed regularly...
  16. ncbi request reprint Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage
    Serge Gilberg
    Département de médecine générale, Faculte de Medecine Necker Enfants Malades, Paris, France
    J Infect Dis 186:415-8. 2002
    ..Pertussis should be considered for diagnosis of acute and chronic cough in adults. Future studies should evaluate the public health interest of booster doses of pertussis vaccine in adults...
  17. pmc Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis
    Elisabeth Njamkepo
    Institut Pasteur, Unité de Prévention et Thérapies Moléculaires des Maladies Humaines, CNRS URA 3012, 25 rue du Dr Roux 75724 Paris, Cedex 15, France
    J Clin Microbiol 49:4347-8. 2011
    ..Bordetella holmesii DNA was detected in 20.3% samples collected from adolescents and adults...
  18. doi request reprint Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
    Viviane Chenal-Francisque
    Institut Pasteur, CNRS URA, Paris, France
    Res Microbiol 160:330-6. 2009
    ..Genomic analyses of this region indicate no polymorphism in B. pertussis and B. parapertussis regions, but substantial variability in B. bronchiseptica that might be linked to the various niches of this species...
  19. doi request reprint In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
    Nicolas Hegerle
    Institut Pasteur, 25 28 Rue du Dr Roux, 75015 Paris, France CNRS URA3012, France
    Microbes Infect 15:399-408. 2013
    ..5% (79/81) of B. bronchiseptica isolates produced BteA in-vitro but only the latter was capable of inducing an in-vivo immune response. No in-vitro or in-vivo production of BteA was detected by any of the B. parapertussis isolates tested...
  20. ncbi request reprint Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization
    Valerie Caro
    Molecular Prevention and Therapy of Human Diseases Unit, Institut Pasteur, FRE CNRS 2849, National Center of Reference of Whooping Cough and Other Bordetelloses, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Microbes Infect 8:2228-35. 2006
    ..This decrease in diversity is essentially due to loss of genes and pseudogenes. The genes deleted are most of the time flanked by insertion sequences...
  21. ncbi request reprint Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations
    Odile Launay
    Faculte de Medecine, Universite Paris Descartes, Paris, France
    Hum Vaccin 5:341-6. 2009
    ..They also indicate the need for better implementation of the current recommendations for pertussis-vaccine boosters in adults...
  22. ncbi request reprint Epidemiology of whooping cough & typing of Bordetella pertussis
    Nicolas Hegerle
    Institut Pasteur Prevention and Molecular Therapy of Human Diseases, 25 28 Rue du Dr Roux, F 75015, Paris, France
    Future Microbiol 8:1391-403. 2013
    ....
  23. pmc Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate
    Karine Dalet
    Unité Prévention et Thérapie Moléculaires des Maladies Humaines, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France
    Infect Immun 72:4874-7. 2004
    ..No difference was observed between the two clones in murine and cellular models, probably due to the high instability of the cya locus duplication...
  24. doi request reprint Septic arthritis caused by Bordetella holmesii in an adolescent with chronic haemolytic anaemia
    Didier Moissenet
    Service de Microbiologie, Hopital Armand Trousseau, Assistance Publique Hopitaux de Paris, Faculte de Medecine, Universite Pierre et Marie Curie Paris 6, Paris, France
    J Med Microbiol 60:1705-7. 2011
    ..B. holmesii was identified by 16S rRNA gene sequence analysis. The patient outcome was favourable. To our knowledge, this is the first case of B. holmesii septic arthritis in an asplenic patient...
  25. ncbi request reprint Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host
    Yongzheng Wu
    Unité de Défense Innée et Inflammation, Institut Pasteur, Paris, France
    Biochimie 92:583-7. 2010
    ..It can be used as a therapeutic agent in adjunct with current therapy to treat bacteria resistant to multiple antibiotics...
  26. pmc Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?
    Valerie Caro
    Institut Pasteur, Molecular Prevention and Therapy of Human Diseases Unit, URA CNRS 3012, National Center of Reference of Whooping Cough and Bordetelloses, Paris, France
    J Clin Microbiol 46:2125-8. 2008
    ..We identified genetic regions specific to recent isolates, old isolates, and isolates of B. parapertussis and B. bronchiseptica species. We conclude that Tohama I strain is not representative of the B. pertussis species...
  27. doi request reprint Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history
    Sylvie Larnaudie
    DASES, Service des vaccinations, Paris, France
    Hum Vaccin 6:829-34. 2010
    ..These results validate a vaccination schedule routinely used for years that rapidly elicits effective immunization against diphtheria, tetanus, poliomyelitis and pertussis...
  28. ncbi request reprint [Impact of vaccination on the infectious diseases epidemiology: example of pertussis]
    Nicole Guiso
    Unité de Prévention et Thérapies des Maladies Humaines, FRE CNRS 2849, Centre National de Reference de la Coqueluche et Autres Bordetelloses, Institut Pasteur, 25, rue du Docteur Roux, 75724 Paris Cedex 15, France
    Med Sci (Paris) 23:399-403. 2007
    ..The new goal now is to give information to medical students and health care workers in general in order to increase adolescent and adult's vaccination coverage...
  29. ncbi request reprint [Why still whooping cough?]
    Nicole Guiso
    Unité Prévention et Thérapie Moléculaires des Maladies Humaines, Centre National de Reference de la Coqueluche et Autres Bordetelloses, FRE CNRS 2849, Institut Pasteur, 25, rue du Docteur Roux, 75724 Paris
    Rev Prat 55:1287-92. 2005
    ..The disease affects now adolescents and adults who contaminate new-borns too young to be vaccinated. For this reason, many countries including France, decided to add vaccine boosters for adolescents and young adults...
  30. pmc Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate
    Stephane Bonacorsi
    Laboratoire d études de génétique bactérienne dans les infections de l enfant EA 3105, Universite Denis Diderot Paris 7, Service de Microbiologie, Paris, France
    J Clin Microbiol 44:3830-2. 2006
    ..This case underscores the need for rapid and sensitive PCR diagnosis in VLBW neonates and in parents with clinical signs of pertussis and suggests that standard treatment may not be appropriate for VLBW neonates...
  31. ncbi request reprint Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies
    Valerie Caro
    Institut Pasteur, Molecular Prevention and Therapy for Human Diseases Unit, Institut Pasteur, Paris, France
    Microbes Infect 7:976-82. 2005
    ..There was no evidence of geographic clustering, except that one new profile subgroup was predominantly found in one country. This study provides a baseline for continued surveillance of the B. pertussis population in Europe...
  32. pmc Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells
    Laurence Bassinet
    Unité Prévention et Thérapie Moléculaires des Maladies Humaines, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France
    Infect Immun 72:5530-3. 2004
    ..This finding confirms the important role of adenylate cyclase-hemolysin in the pathogenicity of the bacterium...
  33. doi request reprint Development of real-time PCR assay for differential detection of Bordetella bronchiseptica and Bordetella parapertussis
    Anette Tizolova
    Institute of Chemical Technology, Department of Biochemistry and Microbiology, Technicka 5, 166 28 Prague 6, Czech Republic Institut Pasteur, Unité Prévention et Thérapie Moléculaires des Maladies Humaines, 25 rue du Dr Roux, 75015 Paris, France Centre National de la Recherche Scientifique CNRS URA 3012, Paris, France
    Diagn Microbiol Infect Dis 78:347-51. 2014
    ..bronchiseptica and B. parapertussis tested. The second PCR assay detected only the DNA of B. parapertussis clinical isolates, thereby allowing discrimination between B. parapertussis and B. bronchiseptica. ..
  34. ncbi request reprint Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity
    E Njamkepo
    Unité des Bordetella, Institut Pasteur, 25 rue du Dr Roux, 75724 Cedex 15, Paris, France
    Vaccine 20:1290-4. 2002
    ....
  35. doi request reprint The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010
    Nicole Guiso
    Institut Pasteur, Molecular Prevention and Therapy Unit, 75724 Paris Cedex 15, France
    Vaccine 29:1115-21. 2011
    ..This article provides a current guide on the appropriate use of laboratory diagnostics and optimal surveillance methodologies to assist countries in the control of pertussis disease...
  36. ncbi request reprint Pertussis is back and now what?
    Nicole Guiso
    Institut Pasteur Unité des Bordetella, Paris, France
    Adv Exp Med Biol 549:105-8. 2004
  37. pmc Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract
    Pascale Gueirard
    Unité des Bordetella, Institut Pasteur, Paris, France
    Infect Immun 71:4137-43. 2003
    ..Later during the infectious process, the bacteria persist mainly in the nasal cavity...
  38. pmc Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes
    Etienne Patin
    Centre National de la Recherche Scientifique, CNRS, FRE 2849, Unit of Molecular Prevention and Therapy of Human Diseases, Paris, France
    Am J Hum Genet 78:423-36. 2006
    ..On the whole, the patterns observed for NAT2 well illustrate how geographically and temporally fluctuating xenobiotic environments may have influenced not only our genome variability but also our present-day susceptibility to disease...